[ALNY] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
31-Oct-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 4.99%
YoY- 14.98%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 264,306 187,633 125,853 70,061 2,069 17,096 13,651 63.82%
PBT -405,943 -204,236 -252,452 -208,929 -244,837 -122,937 -104,071 25.45%
Tax -23 278 839 -394 445 -3,296 -2,204 -53.23%
NP -405,920 -204,514 -253,291 -208,535 -245,282 -122,937 -104,071 25.45%
Tax Rate - - - - - - - -
Total Cost 670,226 392,147 379,144 278,596 247,351 140,033 117,722 33.60%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -153.58 -109.00 -201.26 -297.65 -11,855.10 -719.10 -762.37 -23.42%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -3.32 -1.72 -2.18 -1.92 -2.43 -1.34 -1.21 18.31%
EPS Diluted -3.32 -1.72 -2.18 -1.92 -2.43 -1.34 -1.21 18.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.